Qiming U.S. Ventures Management, LLC

Q2 2025 13F Holdings

  • Location
    bellevue, WA
  • Num holdings

    6

  • Value ($000)

    $23,616

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001909617
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

TOURMALINE BIO INC

COM
89157D105
$11.86M
50 %

741,691

JSPR
JSPR

JASPER THERAPEUTICS INC

COM NEW
471871202
$5.16M
22 %

928,964

KRRO
KRRO

KORRO BIO INC

COM
500946108
$4.60M
20 %

368,085

VTYX
VTYX

VENTYX BIOSCIENCES INC

COM
92332V107
$882.16K
4 %

412,225

HLVX
HLVX

HILLEVAX INC

COM
43157M102
$741.50K
3 %

372,615

---

KEZAR LIFE SCIENCES INC

COM NEW
49372L209
$379.55K
2 %

82,871

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 6 of 6